 BILLERICA, Mass.--BUSINESS WIRE--Quanterix Corporation Nasdaq: QTRX, a company digitizing biomarker analysis to advance the science of precision health, today announced the closing of its previously announced underwritten public offering of 4,107,142 shares of its common stock at a public offering price of 70.00 per share, including 535,714 shares sold pursuant to the full exercise of the underwriters option to purchase additional shares. Gross proceeds from the sale of the shares, before 